AI cancer cures slowed by chip shortage, says UK's biggest tech boss
Arm Holdings CEO Rene Haas predicts that AI will eventually solve complex biological problems like cancer, though current progress is hindered by a global chip shortage. He also anticipates the rise of humanoid robots within five years while expressing skepticism about domestic UK chip manufacturing.
Why it matters
As the leader of a critical semiconductor design firm, Haas's insights highlight the physical infrastructure bottlenecks currently limiting the potential of advanced AI applications.
Image caption, Rene Haas was previously on the board of British pharmaceutical giant AstraZeneca
Economics editor Published 1 hour ago The boss of the biggest UK-headquartered tech firm has said that artifical intelligence will find a cure for cancer that humans cannot in our lifetimes.
Rene Haas, chief executive of Cambridge-based chip designer Arm Holdings, said while modelling how a DNA marker is impacted by cancer was currently "too complex" a problem, computers are "going to solve it" in the future.
Haas also told the BBC that AI would lead to widespread humanoid robots in the next five years, but that its current rapid growth was being held up by a shortage of chips needed to build data centres.
However, he was sceptical about the idea chips could be manufactured in the UK in the future.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in